These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31282475)
1. LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM. Chiduza GN; Johnson RM; Wright GSA; Antonyuk SV; Muench SP; Hasnain SS Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):660-669. PubMed ID: 31282475 [TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc. Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781 [TBL] [Abstract][Full Text] [Related]
3. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Yan R; Zhao X; Lei J; Zhou Q Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids. Rodriguez CF; Escudero-Bravo P; Díaz L; Bartoccioni P; García-Martín C; Gilabert JG; Boskovic J; Guallar V; Errasti-Murugarren E; Llorca O; Palacín M Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34848541 [TBL] [Abstract][Full Text] [Related]
5. Consensus mutagenesis approach improves the thermal stability of system x Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372 [TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells. Le Vee M; Jouan E; Lecureur V; Fardel O Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329 [TBL] [Abstract][Full Text] [Related]
7. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2. Jeckelmann JM; Fotiadis D Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505 [TBL] [Abstract][Full Text] [Related]
8. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer. Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter. Yan R; Li Y; Müller J; Zhang Y; Singer S; Xia L; Zhong X; Gertsch J; Altmann KH; Zhou Q Cell Discov; 2021 Mar; 7(1):16. PubMed ID: 33758168 [TBL] [Abstract][Full Text] [Related]
10. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer. Ichinoe M; Mikami T; Yanagisawa N; Yoshida T; Hana K; Endou H; Okayasu I; Sengoku N; Ogata H; Saegusa M; Shibuya K; Murakumo Y J Clin Pathol; 2021 Sep; 74(9):589-595. PubMed ID: 32907912 [TBL] [Abstract][Full Text] [Related]
11. CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections. Vection S; O'Callaghan D; Keriel A FEMS Microbiol Rev; 2022 Sep; 46(5):. PubMed ID: 35595511 [TBL] [Abstract][Full Text] [Related]
12. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity. Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494 [TBL] [Abstract][Full Text] [Related]
13. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer. Lu X Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820 [TBL] [Abstract][Full Text] [Related]
14. Structure and mechanisms of transport of human Asc1/CD98hc amino acid transporter. Rullo-Tubau J; Martinez-Molledo M; Bartoccioni P; Puch-Giner I; Arias Á; Saen-Oon S; Stephan-Otto Attolini C; Artuch R; Díaz L; Guallar V; Errasti-Murugarren E; Palacín M; Llorca O Nat Commun; 2024 Apr; 15(1):2986. PubMed ID: 38582862 [TBL] [Abstract][Full Text] [Related]
15. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Digomann D; Linge A; Dubrovska A Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435 [TBL] [Abstract][Full Text] [Related]
16. The structure of the human 4F2hc-LAT1 heteromeric amino acid transporter. Fotiadis D; Jeckelmann JM Sci China Life Sci; 2019 Jun; 62(6):848-850. PubMed ID: 31076972 [No Abstract] [Full Text] [Related]
17. Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids. Vilches C; Boiadjieva-Knöpfel E; Bodoy S; Camargo S; López de Heredia M; Prat E; Ormazabal A; Artuch R; Zorzano A; Verrey F; Nunes V; Palacín M J Am Soc Nephrol; 2018 Jun; 29(6):1624-1635. PubMed ID: 29610403 [No Abstract] [Full Text] [Related]
18. Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol. Dickens D; Chiduza GN; Wright GS; Pirmohamed M; Antonyuk SV; Hasnain SS Sci Rep; 2017 Mar; 7():43580. PubMed ID: 28272458 [TBL] [Abstract][Full Text] [Related]
19. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications. Kahlhofer J; Teis D Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306 [TBL] [Abstract][Full Text] [Related]
20. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2. Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]